These groups include children and adolescents who are still in the active growth stage, individuals reliant on medications or insulin injections to manage blood sugar levels (especially those with type 1 diabetes), individuals dealing with acute illnesses, eating disorders, pregnant or breastfeeding women, and those with severe kidney or liver diseases or cancer. The gene discussed is INS; the disease is type 1 diabetes mellitus.